Schedule 13G ownership disclosure
Nurix Therapeutics Inc
Security class unavailable · CUSIP: 67080M103
Event date: 2020-07-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,320,784
- Percent of class
- 6.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-089591
- Form type
- SC 13G
- Filer
- Foresite Capital Fund IV, L.P.
- CIK
- CIK 1704131
- Filed
- Aug 03, 2020
- Reporting period
- Jul 24, 2020
- Description
- Schedule 13G beneficial ownership